Article info
PDFOriginal article
Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker
- Correspondence to Johanne Lade Keller, Institute of Pathology, Aarhus University Hospital, Noerrebrogade 44, Aarhus C DK-8000, Denmark; johanneromer{at}hotmail.com
Citation
Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker
Publication history
- Received December 10, 2013
- Revised February 2, 2014
- Accepted February 6, 2014
- First published March 7, 2014.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions